Chances are that you’re going to get an Epstein-Barr virus (EBV) infection at some point in your life, so you may be interested in new treatments for the virus. Recently, scientists have admitted that vitamin C may be an answer to EBV – which can cause mononucleosis, chronic fatigue syndrome, and Hodgkins’ disease. Can you really kill EBV with vitamin C? A research study published in the May edition of the journal Medical Science Monitor looked at whether high-dose vitamin C can kill EBV. The authors had looked at patients from their clinic who had had diagnoses of EBV infection, mononucleosis, chronic fatigue syndrome, or fatigue between 1997 and 2006. Some of the patients had been treated with intravenous vitamin C. Can you guess what they found? Looks like the Epstein-Barr viral infection can’t survive in a vitamin C environment The scientific evidence is clear – vitamin C does decrease EBV levels. As study authors Nina Mirikova and Ronald Hunninghake wrote, “Our data provides evidence that high dose intravenous vitamin C therapy has a positive effect on disease duration and reduction of viral antibody levels.”
That is, they found vitamin C to help patients get over mononucleosis faster, and individuals infected with EBV had lower levels of the virus after receiving vitamin C treatment. They made the following conclusions. Patients with higher levels of vitamin C before treatment tended to have lower levels of EBV virus, which suggests that low vitamin C allows EBV virus to grow faster. EBV levels dropped by nearly half after vitamin C treatment. Those who had at least five vitamin C treatments recovered faster than patients without vitamin C treatment. To kill EBV – how much vitamin C is enough? The study participants received 7 to 50 grams of vitamin C. That’s a much higher level than recommended by most government health agencies. As ridiculous as this may sound, those same ‘intelligent’ health experts suggest that 60 milligrams (or 0.060 grams) is enough for good health. Unfortunately, when dealing with a serious health crisis, “government approved” nutritional guidelines are simply NOT enough.
Obviously, you’re not going to be able to get 7 to 50 grams (7,000 to 50,000 milligrams) from diet alone because that would be a full-time job – to say the least. For high dosages, it’s always best to work with an experienced physician trained in the administration of IV protocols. What are the best sources of vitamin C in the diet? Naturally, even when feeling great, you should try to consume as many antioxidant-rich foods as possible. The health benefits of eating a nutrient dense diet include, improved heart and immune function – especially when receiving a high amount of vitamin C from the diet. And, just in case you’re new to this information, we’re talking about amounts in the milligrams – not grams. As a general ‘health rule’, eat plenty of fruits and vegetables, such as: Citrus fruits like, camu camu Freshly prepared juices like, carrrot/apple/beet/lemon Red and green bell peppers Tomatoes and tomato juice Sweet potatoes or yams
Of course, if you can, always buy organic foods. If you find the local supermarket is too expensive – get to a local, farmers market and get to know your local farmer. The food is fresher and more delicious plus, in many cases, you’ll pay less at farmers markets or direct from a farmer. Keeping your immune system strong with a healthy diet is the first step in preventing EBV infection and stopping EBV infection from turning into mononucleosis or another health condition. If you do have high EBV levels, you might consider asking your doctor about IV vitamin C today. Editor’s note: The NaturalHealth365 Store offers the finest quality vitamin C powder on the market. Click here to order today. » Vaccine World Summit » 7-Day Juice Cleanse Tagged with: chronic fatigue syndrome ebv infection Epstein-Barr viral infection Ronald hunninghake vitamin C September 2014 Vol. 6 Issue 9 Study demonstrates promising results for common naturopathic treatment
Mikirova N, Casciari J, Riordan N, Hunninghake R. Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients. J Transl Med. 2013;11(1):191.Riordan HD, Hunninghake RB, Riordan NH, et a.: Intravenous ascorbic acid: protocol for its application and use. P R Health Sci J. 2003;22(3):287-290.Cohen JI. N Engl J Med. 2000;343(7):481-492.Rickinson AB, Kieff E. Epstein-Barr virus. In: Knipe DM, Howley PM, eds. Fields Virology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; Balfour HH Jr, Holman CJ, Hokanson KM, et al. A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis. J Infect Dis. 2005;192(9):1505-1512.Luzuriaga K, Sullivan JL. N Engl J Med. 2010;362(21):1993-2000.Okano M, Gross, T. Acute or chronic life-threatening diseases associated with Epstein-barr virus infection. Am J Med Sci. 2012;343(6):483-489.Ebell MH. Epstein-Barr virus infectious mononucleosis.
CD8+ T-cell deficiency, Epstein-Barr virus infection, vitamin D deficiency, and steps to autoimmunity: a unifying hypothesis. Autoimmune Dis. 2012;2012:189096.Hess RD. Routine Ebstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years. 2004;42(8):3381-3387.Okano M, Kawa K, Kimura H, et al. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. 2005;80(1):64-69.Häusler M, Scheithauer S, Ritter K, Kleines M. Molecular diagnosis of Epstein Barr virus. Expert Rev Mol Diagn. 2003;3(1):81-92.Gulley ML. Molecular diagnosis of Epstein-Barr virus-related diseases. 2001;3(1):1-10.Odumade OA, Hogquist KA, Balfour HH Jr. Progress and problems in understanding and managing primary Epstein-Barr virus infections. Clin Microbiol Rev. 2011;24(1):193-209.Thorley-Lawson DA, Poodry CA. Identification and isolation of the main component (gp350-gp220) of Epstein-Barr virus responsible for generating neutralizing antibodies in vivo. 1982;43(2):730-736.Okano M. Therapeutic approaches for severe Epstein-Barr virus infection.
1997;14(2):109-119.Tynell E, Aurelius E, Brandell A, et al. Acyclovir and prednisolone treatment of acute infectious mononucleosis: a multicenter, double-blind, placebo-controlled study. J Infect Dis. 1996;174(2):324-331.Yenamandra SP, Hellman U, Kempkes B, et al. Epstein-Barr virus encoded EBNA-3 binds to vitamin D receptor and blocks activation of its target genes. Cell Mol Life Sci. 2010;67(24):4249-4256.Cantorna MT, Yu S, Bruce D. The paradoxical effects of vitamin D on type 1 mediated immunity. Mol Aspects Med. 2008;29(6):369-375.Hergenhahn M, Soto U, Weninger A, et al. The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells. Iwatsuki K, Akihisa T, Tokuda H, et al. Lucidenic acids P and Q, methyl lucidenate P, and other triterpenoids from the fungus Ganoderma lucidum and their inhibitory effects on Epstein-Barr virus activation. 2003;66(12):1582-1585.Chen JY, Chang CY, Feng PH, Chu CC, So EC, Hu ML. Plasma vitamin C is lower in postherpetic neuralgia patients and administration of vitamin C reduces spontaneous pain but not brush-evoked pain.